{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T03:30:49Z","timestamp":1788233449276,"version":"build-2803163510"},"reference-count":95,"publisher":"Walter de Gruyter GmbH","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,10,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Huntington\u2019s disease (HD), a neurodegenerative disorder caused by an expansion of the huntingtin triplet (Htt), is clinically characterized by cognitive and neuropsychiatric alterations. Although these alterations appear to be related to mutant Htt (mHtt)-induced neurotoxicity, several other factors are involved. The gut microbiota is a known modulator of brain-gut communication and when altered (dysbiosis), several complaints can be developed including gastrointestinal dysfunction which may have a negative impact on cognition, behavior, and other mental functions in HD through several mechanisms, including increased levels of lipopolysaccharide, proinflammatory cytokines and immune cell response, as well as alterations in Ca<jats:sup>2+<\/jats:sup> signaling, resulting in both increased intestinal and blood-brain barrier (BBB) permeability. Recently, the presence of dysbiosis has been described in both transgenic mouse models and HD patients. A bidirectional influence between host brain tissues and the gut microbiota has been observed. On the one hand, the host diet influences the composition and function of microbiota; and on the other hand, microbiota products can affect BBB permeability, synaptogenesis, and the regulation of neurotransmitters and neurotrophic factors, which has a direct effect on host metabolism and brain function. This review summarizes the available evidence on the pathogenic synergism of dysbiosis and homocysteine, and their role in the transgression of BBB integrity and their potential neurotoxicity of HD.<\/jats:p>","DOI":"10.1515\/revneuro-2021-0164","type":"journal-article","created":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T06:52:58Z","timestamp":1649746378000},"page":"819-827","source":"Crossref","is-referenced-by-count":11,"title":["Gut dysbiosis and homocysteine: a couple for boosting neurotoxicity in Huntington disease"],"prefix":"10.1515","volume":"33","author":[{"given":"Juan Carlos","family":"Mart\u00ednez-Lazcano","sequence":"first","affiliation":[{"name":"Laboratorio de Neurofarmacolog\u00eda Molecular y Nanotecnolog\u00eda , Instituto Nacional de Neurolog\u00eda y Neurocirug\u00eda MVS , Mexico City 14629 , Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edith","family":"Gonz\u00e1lez-Guevara","sequence":"additional","affiliation":[{"name":"Laboratorio de Neurofarmacolog\u00eda Molecular y Nanotecnolog\u00eda , Instituto Nacional de Neurolog\u00eda y Neurocirug\u00eda MVS , Mexico City 14629 , Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Boll","sequence":"additional","affiliation":[{"name":"Laboratorio de Investigaci\u00f3n cl\u00ednica, Cl\u00ednica de Ataxias y Coreas, Enfermedades Neurodegenerativas Raras , Instituto Nacional de Neurolog\u00eda y Neurocirug\u00eda MVS , Mexico City 14629 , Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3332-5840","authenticated-orcid":false,"given":"Graciela","family":"C\u00e1rdenas","sequence":"additional","affiliation":[{"name":"Departamento de Neurolog\u00eda y Enfermedades Neuro-Infecciosas , Instituto Nacional de Neurolog\u00eda y Neurocirug\u00eda MVS , Mexico City 14629 , Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2022,4,12]]},"reference":[{"key":"2023040102094233467_j_revneuro-2021-0164_ref_001","doi-asserted-by":"crossref","unstructured":"Abeti, R. and Abramov, A.Y. (2015). Mitochondrial Ca2+ in neurodegenerative disorders. Pharmacol. Res. 99: 377\u2013381, https:\/\/doi.org\/10.1016\/j.phrs.2015.05.007.","DOI":"10.1016\/j.phrs.2015.05.007"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_002","doi-asserted-by":"crossref","unstructured":"Aldaz, T., Nigro, P., S\u00e1nchez-Gomez, A., Painous, C., Planella, L., Santacruz, P., C\u00e1mara, A., Compta, Y., Valldeoriola, F., Marti, M.J., et al.. (2019). Non-motor symptoms in Huntington\u2019s disease: a comparative study with Parkinson\u2019s disease. J.\u00a0Neurol. 266: 1340\u20131350, https:\/\/doi.org\/10.1007\/s00415-019-09263-7.","DOI":"10.1007\/s00415-019-09263-7"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_003","doi-asserted-by":"crossref","unstructured":"Andrich, J., Saft, C., Arz, A., Schneider, B., Agelink, M.W., Kraus, P.H., Kuhn, W., and M\u00fcller, T. (2004). Hyperhomocysteinaemia in treated patients with Huntington\u2019s disease homocysteine in HD. Mov. Disord. 19: 226\u2013228, https:\/\/doi.org\/10.1002\/mds.10629.","DOI":"10.1002\/mds.10629"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_004","doi-asserted-by":"crossref","unstructured":"Andrich, J.E., Wobben, M., Klotz, P., Goetze, O., and Saft, C. (2009). Upper gastrointestinal findings in Huntington\u2019s disease: patients suffer but do not complain. J.\u00a0Neural Transm. (Vienna) 116: 1607\u20131611, https:\/\/doi.org\/10.1007\/s00702-009-0310-1.","DOI":"10.1007\/s00702-009-0310-1"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_005","doi-asserted-by":"crossref","unstructured":"Aziz, N.A., Anguelova, G.V., Marinus, J., van Dijk, J.G., and Roos, R.A. (2010). Autonomic symptoms in patients and pre-manifest mutation carriers of Huntington\u2019s disease. Eur. J.\u00a0Neurol. 17: 1068\u20131074, https:\/\/doi.org\/10.1111\/j.1468-1331.2010.02973.x.","DOI":"10.1111\/j.1468-1331.2010.02973.x"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_006","doi-asserted-by":"crossref","unstructured":"Bezprozvanny, I. (2009). Calcium signaling and neurodegenerative diseases. Trends Mol. Med. 15: 89\u2013100, https:\/\/doi.org\/10.1016\/j.molmed.2009.01.001.","DOI":"10.1016\/j.molmed.2009.01.001"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_007","doi-asserted-by":"crossref","unstructured":"Bhatia, P. and Singh, N. (2015). Homocysteine excess: delineating the possible mechanism of neurotoxicity and depression. Fundam. Clin. Pharmacol. 29: 522\u2013528, https:\/\/doi.org\/10.1111\/fcp.12145.","DOI":"10.1111\/fcp.12145"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_008","doi-asserted-by":"crossref","unstructured":"Bj\u00f6rkqvist, M., Wild, E.J., Thiele, J., Silvestroni, A., Andre, R., Lahiri, N., Raibon, E., Lee, R.V., Benn, C.L., Soulet, D., et al.. (2008). A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington\u2019s disease. J.\u00a0Exp. Med. 205: 1869\u20131877, https:\/\/doi.org\/10.1084\/jem.20080178.","DOI":"10.1084\/jem.20080178"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_009","doi-asserted-by":"crossref","unstructured":"Boldyrev, A.A., Bryushkova, E.A., Mashkina, A., and Vladychenskaya, E. (2013). Why is homocysteine toxic for the nervous and immune systems? Curr. Aging. Sci. 6: 29\u201336, https:\/\/doi.org\/10.1134\/s0006297912020022.","DOI":"10.2174\/18746098112059990007"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_010","doi-asserted-by":"crossref","unstructured":"Boutell, J.M., Wood, J.D., Harper, P.S., and Lones, A.L. (1998). Huntingtin interacts with cystathionine beta-synthase. Hum. Mol. Genet. 7: 371\u2013378, https:\/\/doi.org\/10.1093\/hmg\/7.3.371.","DOI":"10.1093\/hmg\/7.3.371"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_011","doi-asserted-by":"crossref","unstructured":"Braniste, V., Al-Asmakh, M., Kowal, C., Anuar, F., Abbaspour, A., Toth, M., Morecka, A., Bakocevic, N., Ng, L.G., Kundu, P., et al.. (2014). The gut microbiota influences blood-brain barrier permeability in mice. Sci. Transl. Med. 6: 263ra158, https:\/\/doi.org\/10.1126\/scitranslmed.3009759.","DOI":"10.1126\/scitranslmed.3009759"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_012","doi-asserted-by":"crossref","unstructured":"Chakaroun, R.M., Massier, L., and Kovacs, P. (2020). Gut Microbiome, intestinal permeability, and tissue bacteria in metabolic disease: perpetrators or bystanders? Nutrients 12: 1082, https:\/\/doi.org\/10.3390\/nu12041082.","DOI":"10.3390\/nu12041082"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_013","doi-asserted-by":"crossref","unstructured":"Chen, H., Fitzgerald, R., Brown, A.T., Qureshi, I., Breckenridge, J., Kazi, R., Wang, Y., Wu, Y., Zhang, X., Mukunyadzi, P., et al.. (2005). Identification of a homocysteine receptor in the peripheral endothelium and its role in proliferation. J.\u00a0Vasc. Surg. 41: 853\u2013860, https:\/\/doi.org\/10.1016\/j.jvs.2005.02.021.","DOI":"10.1016\/j.jvs.2005.02.021"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_014","doi-asserted-by":"crossref","unstructured":"Chen, J.Y., Ye, Z.X., Wang, X.F., Chang, J., Yang, M.W., Zhong, H.H., Hong, F.F., and Yang, S.L. (2018). Nitric oxide bioavailability dysfunction involves in atherosclerosis. Biomed. Pharmacother. 97: 423\u2013428, https:\/\/doi.org\/10.1016\/j.biopha.2017.10.122.","DOI":"10.1016\/j.biopha.2017.10.122"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_015","doi-asserted-by":"crossref","unstructured":"Christine, C.W., Auinger, P., Joslin, A., Yelpaala, Y., Green, R., and Parkinson Study Group-DATATOP investigators (2018). Vitamin B12 and homocysteine levels predict different outcomes in early Parkinson\u2019s disease. Mov. Disord. 33: 762\u2013770, https:\/\/doi.org\/10.1002\/mds.27301.","DOI":"10.1002\/mds.27301"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_016","unstructured":"Craufurd, D., Thompson, J.C., and Snowden, J.S. (2001). Behavioral changes in Huntington disease. Cognit. Behav. Neurol. 14: 219\u2013226."},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_017","doi-asserted-by":"crossref","unstructured":"Czeredys, M., Vigont, V.A., Boeva, V.A., Mikoshiba, K., Kaznacheyeva, E.V., and Kuznicki, J. (2018). Huntingtin associated protein 1A regulates store-operated calcium entry un medium spiny neurons from transgenic YAC128 mice, a model of Huntington\u2019s disease. Front. Cell. Neurosci. 12: 381, https:\/\/doi.org\/10.3389\/fncel.2018.00381.","DOI":"10.3389\/fncel.2018.00381"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_096","doi-asserted-by":"crossref","unstructured":"Di Pardo, A. and Maglione, V. (2018). The S1P Axis: new exciting route for treating Huntington\u2019s disease. Trends Pharmacol. Sci. 39: 468\u2013480.","DOI":"10.1016\/j.tips.2018.02.009"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_019","doi-asserted-by":"crossref","unstructured":"Djouss\u00e9, L., Knowlton, B., Cupples, L.A., Marder, K., Shoulson, I., and Myers, R.H. (2002). Weight loss in early stage of Huntington\u2019s disease. Neurology 59: 1325\u20131330, https:\/\/doi.org\/10.1212\/01.wnl.0000031791.10922.cf.","DOI":"10.1212\/01.WNL.0000031791.10922.CF"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_094","doi-asserted-by":"crossref","unstructured":"Dong, B. and Wu, R. (2020). Plasma homocysteine, folate and vitamin B12 levels in Parkinson\u2019s disease in China: a meta-analysis. Clin Neurol Neurosurg. 188: 105587, https:\/\/doi.org\/10.1016\/j.clineuro.2019.1055878.","DOI":"10.1016\/j.clineuro.2019.105587"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_021","doi-asserted-by":"crossref","unstructured":"Drouin-Ouellet, J., Sawiak, S.J., Cisbani, G., Lagac\u00e9, M., Kuan, W.L., Saint-Pierre, M., Dury, R.J., Alata, W., St-Amour, I., Mason, S.L., et al.. (2015). Cerebrovascular and blood-brain barrier impairments in Huntington\u2019s disease: potential implications for its pathophysiology. Ann. Neurol. 78: 160\u2013177, https:\/\/doi.org\/10.1002\/ana.24406.","DOI":"10.1002\/ana.24406"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_022","doi-asserted-by":"crossref","unstructured":"Du, G., Dong, W., Yang, Q., Yu, X., Ma, J., Gu, W., and Huang, Y. (2021). Altered gut microbiota related to inflammatory responses in patients with Huntington\u2019s disease. Front. Immunol. 11: 603594, https:\/\/doi.org\/10.3389\/fimmu.2020.603594.","DOI":"10.3389\/fimmu.2020.603594"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_023","doi-asserted-by":"crossref","unstructured":"Duran-Vilaregut, J., del Valle, J., Camins, A., Pall\u00e0s, M., Pelegr\u00ed, C., and Vilaplana, J. (2009). Blood-brain barrier disruption in the striatum of rats treated with 3-nitropropionic acid. Neurotoxicology 30: 136\u2013143, https:\/\/doi.org\/10.1016\/j.neuro.2008.10.007.","DOI":"10.1016\/j.neuro.2008.10.007"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_024","doi-asserted-by":"crossref","unstructured":"Fitzgerald, E., Murphy, S., and Martinson, H.A. (2019). Alpha-synuclein pathology and the role of the microbiota in Parkinson\u2019s disease. Front. Neurosci. 13: 369, https:\/\/doi.org\/10.3389\/fnins.2019.00369.","DOI":"10.3389\/fnins.2019.00369"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_025","unstructured":"Geng, Y.J. and Libby, P. (1995). Evidence for apoptosis in advanced human atheroma. Co-localization with interleukin-1\u03b2-converting enzyme. Am. J.\u00a0Pathol. 147: 251\u2013266."},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_026","doi-asserted-by":"crossref","unstructured":"Gerhardt, S. and Mohajeri, M.H. (2018). Changes of colonic bacterial composition in Parkinson\u2019s disease and other neurodegenerative diseases. Nutrients 10: 708, https:\/\/doi.org\/10.3390\/nu10060708.","DOI":"10.3390\/nu10060708"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_027","doi-asserted-by":"crossref","unstructured":"Giacomello, M., Oliveros, J.C., Naranjo, J.R., and Carafoli, E. (2013). Neuronal Ca2+ dyshomeostasis in Huntington disease. Prion 7: 76\u201384, https:\/\/doi.org\/10.4161\/pri.23581.","DOI":"10.4161\/pri.23581"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_028","doi-asserted-by":"crossref","unstructured":"Gubert, C., Kong, G., Renoir, T., and Hannan, A.J. (2020). Exercise, diet and stress as modulators of gut microbiota: implications for neurodegenerative diseases. Neurobiol. Dis. 134: 103621, https:\/\/doi.org\/10.1016\/j.nbd.2019.104621.","DOI":"10.1016\/j.nbd.2019.104621"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_029","doi-asserted-by":"crossref","unstructured":"Hasegawa, T., Ukai, W., Jo, D.G., Xu, X., Mattson, M.P., Nakagawa, M., Araki, W., Saito, T., and Yamada, T. (2005). Homocysteic acid induces intraneuronal accumulation of neurotoxic Abeta42-implications for pathogenesis of Alzheimer\u2019s disease. J.\u00a0Neurosci. Res. 80: 869\u2013876, https:\/\/doi.org\/10.1002\/jnr.20514.","DOI":"10.1002\/jnr.20514"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_030","doi-asserted-by":"crossref","unstructured":"Hoffmann, A., Kann, O., Ohlemeyer, C., Hanisch, U.K., and Kettenmann, H. (2003). Elevation of basal intracellular calcium as a central element in the activation of brain macrophages (microglia): suppression of receptor-evoked calcium signaling and control of release function. J.\u00a0Neurosci. 23: 4410\u20134419, https:\/\/doi.org\/10.1523\/jneurosci.23-11-04410.2003.","DOI":"10.1523\/JNEUROSCI.23-11-04410.2003"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_031","doi-asserted-by":"crossref","unstructured":"Hirschberg, S., Gisevius, B., Duscha, A., and Haghikia, A. (2019). Implications of diet and the gut microbiome in neuroinflammatory and neurodegenerative diseases. Int. J.\u00a0Mol. Sci. 20: 3109, https:\/\/doi.org\/10.3390\/ijms20123109.","DOI":"10.3390\/ijms20123109"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_032","doi-asserted-by":"crossref","unstructured":"Hogan, P.G. and Rao, A. (2015). Store-operated calcium entry: mechanisms and modulation. Biochem. Biophys. Res. Commun. 460: 40\u201349, https:\/\/doi.org\/10.1016\/j.bbrc.2015.02.110.","DOI":"10.1016\/j.bbrc.2015.02.110"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_033","doi-asserted-by":"crossref","unstructured":"Hogan, P.G., Lewis, R.S., and Rao, A. (2010). Molecular basis of calcium signaling in lymphocytes: STIM and ORAI. Annu. Rev. Immunol. 28: 491\u2013533, https:\/\/doi.org\/10.1146\/annurev.immunol.021908.132550.","DOI":"10.1146\/annurev.immunol.021908.132550"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_034","doi-asserted-by":"crossref","unstructured":"Hsiao, H.Y., Chen, Y.C., Huang, C.H., Chen, C.C., Hsu, Y.H., Chen, H.M., Chiu, F.L., Kuo, H.C., Chang, C., and Chern, Y. (2015). Aberrant astrocytes impair vascular reactivity in Huntington disease. Ann. Neurol. 78: 178\u2013192, https:\/\/doi.org\/10.1002\/ana.24428.","DOI":"10.1002\/ana.24428"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_035","doi-asserted-by":"crossref","unstructured":"Isobe, C., Murata, T., Sato, C., and Terayama, Y. (2005). Increase of total homocysteine concentration in cerebrospinal fluid in patients with Alzheimer\u2018s disease and Parkinson\u2018s disease. Life Sci. 77: 1836\u20131843, https:\/\/doi.org\/10.1016\/j.lfs.2005.02.014.","DOI":"10.1016\/j.lfs.2005.02.014"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_036","doi-asserted-by":"crossref","unstructured":"Joseph, R., Nath, G., and Joseraj, M.G. (2011). Elevated plasma homocysteine levels in chronic periodontitis: a hospital-based case-control study. J.\u00a0Periodontol. 82: 439\u2013444, https:\/\/doi.org\/10.1902\/jop.2010.100271.","DOI":"10.1902\/jop.2010.100271"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_037","doi-asserted-by":"crossref","unstructured":"Kettenmann, H., Hanisch, U.K., Noda, M., and Verkhratsky, A. (2011). Physiology of microglia. Physiol. Rev. 91: 461\u2013553, https:\/\/doi.org\/10.1152\/physrev.00011.2010.","DOI":"10.1152\/physrev.00011.2010"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_038","doi-asserted-by":"crossref","unstructured":"Kim, G.W., Gasche, Y., Grzeschik, S., Copin, J.C., Maier, C.M., and Chan, P.H. (2003). Neurodegeneration in striatum induced by the mitochondrial toxin 3-nitropropionic acid: role of matrix metalloproteinase-9 in early blood-brain barrier disruption? J.\u00a0Neurosci. 23: 8733\u20138742, https:\/\/doi.org\/10.1523\/jneurosci.23-25-08733.2003.","DOI":"10.1523\/JNEUROSCI.23-25-08733.2003"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_039","doi-asserted-by":"crossref","unstructured":"Kobal, J., Melik, Z., Cankar, K., Bajrovic, F.F., Meglic, B., Peterlin, B., and Zaletel, M. (2010). Autonomic dysfunction in presymptomatic and early symptomatic Huntington\u2019s disease. Acta Neurol. Scand. 121: 392\u2013399, https:\/\/doi.org\/10.1111\/j.1600-0404.2009.01251.x.","DOI":"10.1111\/j.1600-0404.2009.01251.x"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_040","doi-asserted-by":"crossref","unstructured":"Kolobkova, Y.A., Vigont, V.A., Shalygin, A.V., and Kaznacheyeva, E.V. (2017). Huntington\u2019s disease: calcium dyshomeostasis and pathology models. Acta Naturae 9: 34\u201346, https:\/\/doi.org\/10.32607\/20758251-2017-9-2-34-46.","DOI":"10.32607\/20758251-2017-9-2-34-46"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_041","doi-asserted-by":"crossref","unstructured":"Kong, G., Le Cao, K.A., Judd, L.M., Li, S., Renoir, T., and Hannan, A.J. (2020). Microbiome profiling reveals gut dysbiosis in a transgenic mouse model of Huntington\u2019s disease. Neurobiol. Dis. 135: 104268, https:\/\/doi.org\/10.1016\/j.nbd.2018.09.001.","DOI":"10.1016\/j.nbd.2018.09.001"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_042","doi-asserted-by":"crossref","unstructured":"Kong, G., Ellul, S., Narayana, V.N., Kanojia, K., Ha, H.T.T., Li, S., Renoir, T., Le Cao, C.A., and Hannan, A.J. (2021). An integrated metagenomics and metabolomics approach implicates the microbiota-gut-brain axis in the pathogenesis of Huntington\u2019s disease. Neurobiol. Dis. 148: 105199, https:\/\/doi.org\/10.1016\/j.nbd.2020.105199.","DOI":"10.1016\/j.nbd.2020.105199"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_043","doi-asserted-by":"crossref","unstructured":"Kunisawa, K., Nakashima, N., Nagao, M., Nomura, T., Kinoshita, S., and Hiramatsu, M. (2015). Betaine prevents homocysteine-induced memory impairment via matrix metalloproteinase-9 in the frontal cortex. Behav. Brain Res. 292: 36\u201343, https:\/\/doi.org\/10.1016\/j.bbr.2015.06.004.","DOI":"10.1016\/j.bbr.2015.06.004"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_044","doi-asserted-by":"crossref","unstructured":"Lanska, D.J., Lavine, L., Lanska, M.J., and Schoenberg, B.S. (1988). Huntington\u2019s disease mortality in the United States. Neurology 38: 769\u2013772, https:\/\/doi.org\/10.1212\/wnl.38.5.769.","DOI":"10.1212\/WNL.38.5.769"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_045","doi-asserted-by":"crossref","unstructured":"Levine, J., Stahl, Z., Sela, B.A., Gavendo, S., Ruderman, V., and Belmaker, R.H. (2002). Elevated homocysteine levels in young male patients with schizophrenia. Am. J.\u00a0Psychiatry 159: 1790\u20131792, https:\/\/doi.org\/10.1176\/appi.ajp.159.10.1790.","DOI":"10.1176\/appi.ajp.159.10.1790"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_046","doi-asserted-by":"crossref","unstructured":"Lin, C.Y., Hsu, Y.H., Lin, M.H., Yang, T.H., Chen, H.M., Chen, Y.C., Hsiao, H.Y., Chen, C.C., Chern, Y., and Chang, C. (2013). Neurovascular abnormalities in humans and mice with Huntington\u2019s disease. Exp. Neurol. 250: 20\u201330, https:\/\/doi.org\/10.1016\/j.expneurol.2013.08.019.","DOI":"10.1016\/j.expneurol.2013.08.019"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_047","doi-asserted-by":"crossref","unstructured":"Luckhoff, A. and Busse, R. (1990). Calcium influx into endothelial cells and formation of endothelium-relaxing factor is controlled by the membrane potential. Pfl\u00fcger\u2019s Arch. 416: 305\u2013317, https:\/\/doi.org\/10.1007\/BF00392067.","DOI":"10.1007\/BF00392067"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_048","doi-asserted-by":"crossref","unstructured":"Lurz, E., Horne, R.G., M\u00e4\u00e4tt\u00e4nen, P., Wu, R.Y., Botts, S.R., Rossi, L., Johnson-Henry, K.C., Pierro, A., Surette, M.G., and Sherman, P.M. (2020). Vitamin B12 deficiency alters the gut microbiota in a murine model of colitis. Front. Nutr. 7: 83, https:\/\/doi.org\/10.3389\/fnut.2020.00083.","DOI":"10.3389\/fnut.2020.00083"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_049","doi-asserted-by":"crossref","unstructured":"Macharia, M., Hassan, M.S., Blackhurst, D., Erasmus, R.T., and Matsha, T.E. (2012). The growing importance of PON in cardiovascular health: review. J.\u00a0Cardiovasc. Med. 13: 443\u2013453, https:\/\/doi.org\/10.2459\/jcm.0b013e328354e3ac.","DOI":"10.2459\/JCM.0b013e328354e3ac"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_050","unstructured":"Maes, M. (2008). The cytokine hypothesis of depression: inflammation, oxidative and nitrosative stress (IO & NS) and leaky gut as new targets for adjunctive treatments in depression. Neuro. Endocrinol. Lett. 29: 287\u2013291."},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_051","doi-asserted-by":"crossref","unstructured":"Majewski, L. and Kuznicki, J. (2015). SOCE in neurons: signaling or just refilling. Biochim. Biophys. Acta 1853: 1940\u20131952, https:\/\/doi.org\/10.1016\/j.bbamcr.2015.01.019.","DOI":"10.1016\/j.bbamcr.2015.01.019"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_052","doi-asserted-by":"crossref","unstructured":"Makhro, A.V., Bulygina, E.R., and Boldyrev, A.A. (2007). Effects of homocysteine and homocysteic acid in cerebellar granule cells. Neurochem. J. 1: 127\u2013132, https:\/\/doi.org\/10.1134\/s1819712407020031.","DOI":"10.1134\/S1819712407020031"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_053","doi-asserted-by":"crossref","unstructured":"May, P.C. and Gray, P.N. (1985). L-Homocysteic acid as an alternative cytotoxin for studying glutamate-induced cellular degeneration of Huntington\u2019s disease and normal skin fibroblasts. Life Sci. 37: 1483\u20131489, https:\/\/doi.org\/10.1016\/0024-3205(85)90179-1.","DOI":"10.1016\/0024-3205(85)90179-1"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_054","doi-asserted-by":"crossref","unstructured":"McLarnon, J.G. (2020). Microglial store-operated calcium signaling in health and in Alzheimer\u2019s disease. Curr. Alzheimer Res. 17: 1057\u20131106, https:\/\/doi.org\/10.2174\/1567205018666210119143817.","DOI":"10.2174\/1567205018666210119143817"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_055","doi-asserted-by":"crossref","unstructured":"Morris, M.S., Jacques, P.F., Rosenberg, I.H., and Selhub, J. (2001). Hyperhomocysteinemia associated with poor recall in the third national health and nutrition examination survey. Am. J.\u00a0Clin. Nutr. 73: 927\u2013933, https:\/\/doi.org\/10.1093\/ajcn\/73.5.927.","DOI":"10.1093\/ajcn\/73.5.927"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_056","doi-asserted-by":"crossref","unstructured":"Pacheco-Quinto, J., Rodriguez de Turco, E.B., DeRosa, S., Howard, A., Cruz-Sanchez, F., Sambamurti, K., Refolo, L., Petanceska, S., and Pappolla, M.A. (2006). Hyperhomocysteinemic Alzheimer\u2019s mouse model of amyloidosis shows increased brain amyloid beta peptide levels. Neurobiol. Dis. 22: 651\u2013656, https:\/\/doi.org\/10.1016\/j.nbd.2006.01.005.","DOI":"10.1016\/j.nbd.2006.01.005"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_057","doi-asserted-by":"crossref","unstructured":"Papatheodorou, L. and Weiss, N. (2007). Vascular oxidant stress and inflammation in hyperhomocysteinemia. Antioxid. Redox Signal. 9: 1941\u20131958, https:\/\/doi.org\/10.1089\/ars.2007.1750.","DOI":"10.1089\/ars.2007.1750"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_058","doi-asserted-by":"crossref","unstructured":"Parker, A., Fonseca, S., and Carding, S.R. (2020). Gut microbes and metabolites as modulators of blood-brain barrier integrity and brain health. Gut Microb. 11: 135\u2013137, https:\/\/doi.org\/10.1080\/19490976.2019.1638722.","DOI":"10.1080\/19490976.2019.1638722"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_059","doi-asserted-by":"crossref","unstructured":"Persidsky, Y., Ramirez, S.H., Haorah, J., and Kanmogne, G.D. (2006). Blood-brain barrier: structural components and function under physiologic and pathologic conditions. J.\u00a0Neuroimmune Pharmacol. 1: 223\u2013236, https:\/\/doi.org\/10.1007\/s11481-006-9025-3.","DOI":"10.1007\/s11481-006-9025-3"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_060","doi-asserted-by":"crossref","unstructured":"Perla-Kaj\u00e1n, J. and Jakubowski, H. (2012). Paraoxonase 1 and homocysteine metabolism. Amino Acids 43: 1405\u20131417, https:\/\/doi.org\/10.1007\/s00726-012-1321-z.","DOI":"10.1007\/s00726-012-1321-z"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_061","doi-asserted-by":"crossref","unstructured":"Pi, T., Liu, B., and Shi, J. (2020). Abnormal homocysteine metabolism: an insight of Alzheimer\u2019s disease from DNA methylation. Behav. Neurol. 2020: 8438602, https:\/\/doi.org\/10.1155\/2020\/8438602.","DOI":"10.1155\/2020\/8438602"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_062","doi-asserted-by":"crossref","unstructured":"Poddar, R. and Paul, S. (2009). Homocysteine-NMDA receptor.mediated activation of extracellular signal-regulated kinase leads to neuronal cell death. Neurochemistry 110: 1095\u20131106, https:\/\/doi.org\/10.1111\/j.1471-4159.2009.06207.x.","DOI":"10.1111\/j.1471-4159.2009.06207.x"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_063","doi-asserted-by":"crossref","unstructured":"Qureshi, I., Chen, H., Brown, A.T., Fitzgerald, R., Zhang, X., Breckenridge, J., Kazi, R., Crocker, A.J., Stuhlinger, M.C., Lin, K., et al.. (2005). Homocysteine induced vascular dysregulation is mediated by the NMDA receptor. Vasc. Med. 10: 215\u2013223, https:\/\/doi.org\/10.1191\/1358863x05vm626oa.","DOI":"10.1191\/1358863x05vm626oa"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_064","doi-asserted-by":"crossref","unstructured":"Radulescu, C.I., Garcia-Miralles, M., Sidik, H., Bardile, C.F., Yusof, N., Lee, H.U., Xo, E.X.P., Chu, C.W., Layton, E., Low, D., et al.. (2019). Manipulation of microbiota reveals altered callosal myelination and white matter plasticity in a model of Huntington disease. Neurobiol. Dis. 127: 65\u201375, https:\/\/doi.org\/10.1016\/j.nbd.2019.02.011.","DOI":"10.1016\/j.nbd.2019.02.011"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_065","doi-asserted-by":"crossref","unstructured":"Robbins, A., Ho, A., and Barker, R. (2006). Weight changes in Huntington\u2019s disease. Eur. J.\u00a0Neurol. 13: e7, https:\/\/doi.org\/10.1111\/j.1468-1331.2006.01319.x.","DOI":"10.1111\/j.1468-1331.2006.01319.x"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_066","doi-asserted-by":"crossref","unstructured":"Ross, C.A. and Tabrizi, S.J. (2011). Huntington\u2019s disease: from molecular pathogenesis to clinical treatment. Lancet Neurol. 10: 83\u201398, https:\/\/doi.org\/10.1016\/s1474-4422(10)70245-3.","DOI":"10.1016\/S1474-4422(10)70245-3"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_067","doi-asserted-by":"crossref","unstructured":"Roy, S.S. and Banerjee, S. (2019). Gut microbiota in neurodegenerative disorders. J.\u00a0Neuroimmunol. 328: 98\u2013104, https:\/\/doi.org\/10.1016\/j.jneuroim.2019.01.004.","DOI":"10.1016\/j.jneuroim.2019.01.004"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_068","doi-asserted-by":"crossref","unstructured":"Russo, C., Morabito, F., Luise, F., Piromalli, A., Battaglia, L., Vinci, A., Trapani, Lombardo, V., de Marco, V., Morabito, P., Condino, F., et al.. (2008). Hyperhomocysteinemia is associated with cognitive impairment in multiple sclerosis. J.\u00a0Neurol. 255: 64\u201369, https:\/\/doi.org\/10.1007\/s00415-007-0668-7.","DOI":"10.1007\/s00415-007-0668-7"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_069","doi-asserted-by":"crossref","unstructured":"Rybakova, Y., Akkuratov, E., Kulebyakin, K., Brodskaya, O., Dizhevskaya, A., and Boldyrev, A. (2012). Receptor-mediated oxidative stress in murine cerebellar neurons is accompanied by phosphorylation of MAP (ERK1\/2) kinase. Curr. Aging Sci. 5: 225\u2013230, https:\/\/doi.org\/10.2174\/1874609811205030009.","DOI":"10.2174\/1874609811205030009"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_070","doi-asserted-by":"crossref","unstructured":"Sampson, T.R., Debelius, J.W., Thron, T., Janssen, S., Shastri, G.G., Ilhan, Z.E., Challis, C., Schretter, C.E., Rocha, S., Gradinaru, V., et al.. (2016). Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson\u2019s disease. Cell 167: 1469\u20131480, https:\/\/doi.org\/10.1016\/j.cell.2016.11.018.","DOI":"10.1016\/j.cell.2016.11.018"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_071","doi-asserted-by":"crossref","unstructured":"Scheperjans, F., Aho, V., Pereira, P.A., Koskinen, K., Paulin, L., Pekkonen, E., Haapaniemi, E., Kaakkola, S., Rautio, J.E., Pohja, M, et al.. (2015). Gut microbiota are related to Parkinson\u2019s disease and clinical phenotype. Mov. Disord. 30: 350\u2013358, https:\/\/doi.org\/10.1002\/mds.26069.","DOI":"10.1002\/mds.26069"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_072","doi-asserted-by":"crossref","unstructured":"Sciacca, G. and Cicchetti, F. (2017). Mutant huntingtin protein expression and blood\u2013spinal cord barrier dysfunction in Huntington disease. Ann. Neurol. 82: 981\u2013994, https:\/\/doi.org\/10.1002\/ana.25107.","DOI":"10.1002\/ana.25107"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_073","doi-asserted-by":"crossref","unstructured":"Shaw, P.J. and Feske, S. (2012). Physiological and pathophysiological functions of SOCE in the immune system. Front. Biosci. (Elite Ed.) 4: 2253\u20132268, https:\/\/doi.org\/10.2741\/540.","DOI":"10.2741\/e540"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_074","doi-asserted-by":"crossref","unstructured":"Seshadri, S., Beiser, A., Selhub, J., Jacques, P.F., Rosenberg, I.H., D\u2019Agostino, R.B., Wilson, P.W., and Wolf, P.A. (2002). Plasma homocysteine as a risk factor for dementia and Alzheimer\u2019s disease. N. Engl. J.\u00a0Med. 346: 476\u2013483, https:\/\/doi.org\/10.1056\/nejmoa011613.","DOI":"10.1056\/NEJMoa011613"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_075","doi-asserted-by":"crossref","unstructured":"Signorello, M.G., Pascale, R., and aLeoncini, G. (2002). Effect of homocysteine on arachidonic acid release in human platelets. Eur. J.\u00a0Clin. Invest. 32: 279\u2013284, https:\/\/doi.org\/10.1046\/j.1365-2362.2002.00971.x.","DOI":"10.1046\/j.1365-2362.2002.00971.x"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_076","doi-asserted-by":"crossref","unstructured":"Sorensen, S.A. and Fenger, K. (1992). Causes of death in patients with Huntington\u2019s disease and in unaffected first-degree relatives. J.\u00a0Med. Genet. 29: 911\u2013914, https:\/\/doi.org\/10.1136\/jmg.29.12.911.","DOI":"10.1136\/jmg.29.12.911"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_077","doi-asserted-by":"crossref","unstructured":"Stan, T.L., Soylu-Kucharz, R., Burleigh, S., Prykhodko, O., Cao, L., Franke, N., Sj\u00f6gren, M., Haikal, C., Hallenius, F., and Bj\u00f6rkqvist, M. (2020). Increased intestinal permeability and gut dysbiosis in R6\/2 mouse model of Huntington\u2019s disease. Sci. Rep. 10: 18270, https:\/\/doi.org\/10.1038\/s41598-020-75229-9.","DOI":"10.1038\/s41598-020-75229-9"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_078","doi-asserted-by":"crossref","unstructured":"Tian, L., Shihua, L., Xiaozhong, G., Qiang, C., and Xiao-Jiang, L. (2019). Expression, and localization of Huntingtin-associated protein 1(HAP1) in the human digestive system. Dig. Dis. Sci. 64: 1486\u20131492, https:\/\/doi.org\/10.1007\/s10620-018-5425-5.","DOI":"10.1007\/s10620-018-5425-5"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_079","doi-asserted-by":"crossref","unstructured":"Tang, Y. and Le, W. (2016). Differential roles of M1 and M2 microglia in neurodegenerative diseases. Mol. Neurobiol. 53: 1181\u20131194, https:\/\/doi.org\/10.1007\/s12035-014-9070-5.","DOI":"10.1007\/s12035-014-9070-5"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_080","doi-asserted-by":"crossref","unstructured":"Thaler, R., Agsten, M., Spitzer, S., Paschalis, E.P., Karlic, H., Klaushofer, K., and Varga, F. (2011). Homocysteine suppresses the expression of the collagen cross-linker lysyl oxidase involving IL-6, Fli1, and epigenetic DNA methylation. J.\u00a0Biol. Chem. 286: 5578\u20135588, https:\/\/doi.org\/10.1074\/jbc.m110.166181.","DOI":"10.1074\/jbc.M110.166181"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_081","doi-asserted-by":"crossref","unstructured":"Tomas-Barberan, F.A., Garcia-Villalba, R., Gonzalez-Sarrias, A., Selma, M.V., and Espin, J.C. (2014). Ellagic acid metabolism by human gut microbiota: consistent observation of three urolithin phenotypes in intervention trials, independent of food source, age, and health status. J.\u00a0Agric. Food Chem. 62: 6535\u20136653, https:\/\/doi.org\/10.1021\/jf5024615.","DOI":"10.1021\/jf5024615"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_082","doi-asserted-by":"crossref","unstructured":"Trager, U., Andre, R., Lahiri, N., Magnusson-Lind, A., Weiss, A., Grueninger, S., McKinnon, C., Sirinathsinghji, E., Kahlon, S., Pfister, E.L., et al.. (2014). HTT-lowering reverses Huntington\u2019s disease immune dysfunction caused by NFkappaB pathway dysregulation. Brain 137: 819\u2013833, https:\/\/doi.org\/10.1093\/brain\/awt355.","DOI":"10.1093\/brain\/awt355"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_083","doi-asserted-by":"crossref","unstructured":"Tsao, R. (2010). Chemistry and biochemistry of dietary polyphenols. Nutrients 2: 21231\u201321246, https:\/\/doi.org\/10.3390\/nu2121231.","DOI":"10.3390\/nu2121231"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_084","doi-asserted-by":"crossref","unstructured":"Upchurch, G.R.Jr, Welch, G.N., Fabian, A.J., Freedman, J.E., Johnson, J.L., Keaney, J.F.Jr, and Loscalzo, J. (1997). Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase. J.\u00a0Biol. Chem. 227: 17012\u201317017, https:\/\/doi.org\/10.1074\/jbc.272.27.17012.","DOI":"10.1074\/jbc.272.27.17012"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_085","doi-asserted-by":"crossref","unstructured":"van der Burg, J.M., Winqvist, A., Aziz, N.A., Maat-Schieman, M.L., Roos, R.A., Bates, G.P., Brundin, P., Bj\u00f6rkqvist, M., and Wierup, N. (2011). Gastrointestinal dysfunction contributes to weight loss in Huntington\u2019s disease mice. Neurobiol. Dis. 44: 1\u20138, https:\/\/doi.org\/10.1016\/j.nbd.2011.05.006.","DOI":"10.1016\/j.nbd.2011.05.006"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_086","doi-asserted-by":"crossref","unstructured":"Vigont, V., Kolobkova, Y., Skopin, A., Zimina, O., Zenin, V., Glushankova, L., and Kaznacheyeva, E. (2015). Both Orai1 and TRPC1 are involved in excessive store-operated calcium entry in striatal neurons expressing mutant huntingtin exon 1. Front. Physiol. 6: 337, https:\/\/doi.org\/10.3389\/fphys.2015.00337.","DOI":"10.3389\/fphys.2015.00337"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_087","doi-asserted-by":"crossref","unstructured":"Wasser, C.I., Mercieca, E.C., Kong, G., Hannan, A.J., McKeown, S.J., Glikmann-Johnston, Y., and Stout, J.C. (2020). Gut dysbiosis in Huntington\u2019s disease: associations among gut microbiota, cognitive performance, and clinical outcomes. Brain Commun. 2: fcaa110, https:\/\/doi.org\/10.1093\/braincomms\/fcaa110.","DOI":"10.1093\/braincomms\/fcaa110"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_088","doi-asserted-by":"crossref","unstructured":"Weiss, A., Trager, U., Wild, E.J., Grueninger, S., Farmer, R., Landles, C., Scahill, R.I., Lahiri, N., Haider, S., Macdonald, D., et al.. (2012). Mutant huntingtin fragmentation in immune cells tracks Huntington\u2019s disease progression. J.\u00a0Clin. Invest. 122: 3731\u20133736, https:\/\/doi.org\/10.1172\/jci64565.","DOI":"10.1172\/JCI64565"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_089","doi-asserted-by":"crossref","unstructured":"Wu, L.L.Y. and Zhou, X.F. (2009). Huntingtin associated protein 1 and its functions. Cell Adhes. Migrat. 3: 71\u201376, https:\/\/doi.org\/10.4161\/cam.3.1.7511.","DOI":"10.4161\/cam.3.1.7511"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_095","doi-asserted-by":"crossref","unstructured":"Yilmaz, N. (2012). Relationship between paraoxonase and homocysteine: crossroads of oxidative diseases. Arch. Med. Sci. 8: 138\u2013153, https:\/\/doi.org\/10.5114\/aoms.2012.27294.","DOI":"10.5114\/aoms.2012.27294"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_090","doi-asserted-by":"crossref","unstructured":"Yu, L.C.H. (2018). Microbiota dysbiosis and barrier dysfunction in inflammatory bowel disease and colorectal cancers: exploring a common ground hypothesis. J.\u00a0Biomed. Sci. 25: 79, https:\/\/doi.org\/10.1186\/s12929-018-0483-8.","DOI":"10.1186\/s12929-018-0483-8"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_091","doi-asserted-by":"crossref","unstructured":"Zhang, H.S., Xiao, J.H., Cao, N.H., and Qin, J.F. (2005). Homocysteine inhibits store-mediated calcium entry in human endothelial cells: evidence for involvement of membrane potential and actin cytoskeleton. Mol. Cell. Biochem. 269: 37\u201347, https:\/\/doi.org\/10.1007\/s11010-005-3168-z.","DOI":"10.1007\/s11010-005-3168-z"},{"key":"#cr-split#-2023040102094233467_j_revneuro-2021-0164_ref_092.1","unstructured":"Zhang, S., Al-Maghout, T., Cao, H., Pelzl, L., Salker, M.S., Veldhoen, M., Cheng, A., Lang, F., and Singh, Y. (2019). Gut bacterial metabolite urolithin A"},{"key":"#cr-split#-2023040102094233467_j_revneuro-2021-0164_ref_092.2","doi-asserted-by":"crossref","unstructured":"(UA) mitigates Ca2+ entry in T\u00a0cells by regulating miR-10a-5p. Front. Immunol. 10: 1737, https:\/\/doi.org\/10.3389\/fimmu.2019.01737.","DOI":"10.3389\/fimmu.2019.01737"},{"key":"2023040102094233467_j_revneuro-2021-0164_ref_093","doi-asserted-by":"crossref","unstructured":"Ziemisnska, E., Stafiej, A., and Lazarewicz, J.W. (2003). Role of group I metabotropic glutamate receptors and NMDA receptors\u00a0in homocysteine-evoked acute neurodegeneration of cultured cerebellar granule neurons. Neurochem. Int. 43: 481\u2013492.","DOI":"10.1016\/S0197-0186(03)00038-X"}],"container-title":["Reviews in the Neurosciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/revneuro-2021-0164\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/revneuro-2021-0164\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,2]],"date-time":"2023-04-02T00:23:49Z","timestamp":1680395029000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/revneuro-2021-0164\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,12]]},"references-count":95,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,3,21]]},"published-print":{"date-parts":[[2022,10,26]]}},"alternative-id":["10.1515\/revneuro-2021-0164"],"URL":"https:\/\/doi.org\/10.1515\/revneuro-2021-0164","relation":{},"ISSN":["0334-1763","2191-0200"],"issn-type":[{"value":"0334-1763","type":"print"},{"value":"2191-0200","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,12]]}}}